Strengths

● The company's profit outlook over the next few years is a strong asset.

● With a P/E ratio at 10.37 for the current year and 7.39 for next year, earnings multiples are highly attractive compared with competitors.

● The company is one of the most undervalued, with an "enterprise value to sales" ratio at 0.36 for the 2022 fiscal year.

● The company appears to be poorly valued given its net asset value.

● Given the positive cash flows generated by its business, the company's valuation level is an asset.

● The difference between current prices and the average target price is rather important and implies a significant appreciation potential for the stock.

● Analyst opinion has improved significantly over the past four months.

● Over the past twelve months, analysts' opinions have been strongly revised upwards.


Weaknesses

● The company does not generate enough profits, which is an alarming weak point.

● For the last twelve months, the trend in sales revisions has been clearly going down, which emphasizes downgraded expectations from the analysts.

● For the last four months, the sales outlook for the coming years has been revised downwards. No recovery of the group's activities is yet foreseen.

● For the past year, analysts have significantly revised downwards their profit estimates.

● For the last four months, earnings estimated by analysts have been revised downwards with respect to the next two years.

● The average price target of analysts who are interested in the stock has been significantly revised downwards over the last four months.